Lonza Signs API Manufacturing Deal with Elan

07:04 AM | December 2, 2011 | Deepti Ramesh

Biotechnology company Elan (Dublin) says it has entered into a manufacturing agreement with Lonza for the supply of the active pharmaceutical ingredient (API) for ELND005, which is being developed by...